Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome
Clinical Microbiology Reviews · 12.06.2025 · 38 (2)
DOI: 10.1128/cmr.00178-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 12.06.2025. Verfasst von Allison Kensiski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Immunosuppressive Agents, Gastrointestinal Microbiome, Immunosuppression Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health (NIH), NHLBI NIH HHS.
Abstract (Originalsprache)
Transplant recipients require lifelong, multimodal immunosuppression to prevent rejection by dampening alloreactive immunity. These treatments have long been known to lack antigen specificity. Despite empirically selected long-term immunosuppression regimens, most allografts succumb to alloimmune responses that result in chronic inflammation and scarring. Additionally, immunosuppressive medications themselves contribute to unintended intestinal dysbiosis and metabolic disorders. This review focuses on the effect of immunosuppressant treatments on alloimmunity, gut microbiome, and metabolism, with a particular emphasis on the effects on metabolic disorders. We also outline the shared and unique microbial and metabolic signatures produced by each immunosuppressant class, underlining their distinct impacts on immunity and metabolic homeostasis. These observations underscore the need for a holistic understanding of these drugs’ on- and off-target effects to refine therapeutic strategies, enhance immunosuppression efficacy, and ultimately enhance graft and patient survival. By characterizing these complex interactions, strategies informed by the gut microbiome and host metabolism may offer a promising adjunctive approach to optimizing immunosuppressive regimens and promoting sustained graft acceptance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Allison Kensiski, Bing Ma, Jonathan S Bromberg
Förderung
- NIAID NIH HHS
- HHS | National Institutes of Health (NIH)
- NHLBI NIH HHS
Zitieren
APA
Kensiski, A., Gavzy, S. J., Wu, L., Mas, V., Ma, B., & Bromberg, J. S. (2025). Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome. Clinical Microbiology Reviews, 38(2). https://doi.org/10.1128/cmr.00178-24
Vancouver
Kensiski A, Gavzy SJ, Wu L, Mas V, Ma B, Bromberg JS. Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome. Clinical Microbiology Reviews. 2025;38(2). doi:10.1128/cmr.00178-24
BibTeX
@article{Kensiski2025,
author = {Kensiski, Allison and Gavzy, Samuel J and Wu, Long and Mas, Valeria and Ma, Bing and Bromberg, Jonathan S},
title = {Immunosuppressant imprecision: multidirectional effects on metabolism and microbiome},
journal = {Clinical Microbiology Reviews},
year = {2025},
volume = {38},
number = {2},
doi = {10.1128/cmr.00178-24}
}
EUVIMED